[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病防治指南(2018更新版)[J].传染病信息,2018,31(5):393-402,420.
[2] Estes C,Anstee QM,Arias-Loste MT,et al.Modeling NAFLD disease burden in China,France,Germany,Italy,Japan,Spain,United Kingdom,and United States for the period 2016-2030[J].J Hepatol,2018,69(4):896-904.
[3] Xian YX,Weng JP,Xu F.MAFLD vs.NAFLD: shared features and potential changes in epidemiology,pathophysiology,diagnosis,and pharmacotherapy[J].Chin Med J (Engl),2020,134(1):8-19.
[4] 卓臣义,包崇婵,冯时,等.大黄灵仙胶囊对胆结石小鼠模型法尼醇X受体的影响[J].中国中西医结合杂志,2021,41(7):836-841.
[5] Henkel J,Alfine E,Saín J,et al.Soybean oil-derived poly-unsaturated fatty acids enhance liver damage in NAFLD induced by dietary Cholesterol[J].Nutrients,2018,10(9):1326.
[6] Kazankov K,Jrgensen SMD,Thomsen KL,et al.The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J].Nat Rev Gastroenterol Hepatol,2019,16(3):145-159.
[7] Wallace MC,Friedman SL,Mann DA.Emerging and disease-specific mechanisms of hepatic stellate cell activation[J].Semin Liver Dis,2015,35(2):107-118.
[8] Marí M,Caballero F,Colell A,et al.Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis[J].Cell Metab,2006,4(3):185-198.
[9] Chávez-Talavera O,Tailleux A,Lefebvre P,et al.Bile acid control of metabolism and inflammation in obesity,type 2 diabetes,dyslipidemia,and nonalcoholic fatty liver disease[J].Gastroenterology,2017,152(7):1679-1694.
[10] 郑伟,王雪,韩红翠,等.基于LC-MS研究交泰丸调控睡眠剥夺小鼠胆汁酸代谢变化[J].中国中药杂志,2021,46(20):5382-5392.
[11] Kriaa A,Bourgin M,Potiron A,et al.Microbial impact on cholesterol and bile acid metabolism: current status and future prospects[J].J Lipid Res,2019,60(2):323-332.
[12] 李晓峰,龚敬宇,王建设.胆汁酸的肠肝循环与胆汁淤积性肝病[J].临床肝胆病杂志,2017,33(10):1922-1927.
[13] 蔡昕,覃仁武,刘玉青,等.桂枝通过调控FXR通路改善ANIT诱导的肝内胆汁淤积大鼠模型的机制研究[J].中国中药杂志,2019,44(12):2594-2599.
[14] 许俊,刘少志,王颖,等.利福平在胆汁淤积模型中对多药耐药相关蛋白2表达的影响[J].中国医院药学杂志,2020,40(24):2511-2517,2569.
[15] Matye DJ,Wang H,Luo W,et al.Combined ASBT inhibitor and FGF15 treatment improves therapeutic efficacy in experimental nonalcoholic steatohepatitis[J].Cell Mol Gastroenterol Hepatol,2021,12(3):1001-1019.
[16] Halilbasic E,Claudel T,Trauner M.Bile acid transporters and regulatory nuclear receptors in the liver and beyond[J].J Hepatol,2013,58(1):155-168.
[17] Fukano K,Tsukuda S,Watashi K,et al.Concept of Viral Inhibitors via NTCP[J].Semin Liver Dis,2019,39(1):78-85.
[18] 汪祺,文海若,马双成.以OATP1B1/OATP1B3转运体为作用靶点的何首乌肝毒性成分筛选[J].药物评价研究,2022,45(2):227-233.
[19] 李红,丘燕燕,周俪姗,等.利胆合剂对胆汁淤积大鼠胆汁酸代谢相关蛋白的影响[J].中国医院药学杂志,2021,41(13):1283-1287.
[20] Cai SY,Boyer JL.FXR: a target for cholestatic syndromes[J].Expert Opin Ther Targets,2006,10(3):409-421.
[21] Shih DM,Kast-Woelbern HR,Wong J,et al.A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids[J].J Lipid Res,2006,47(2):384-392.
[22] Qu X,Zhang Y,Zhang S,et al.Dysregulation of BSEP and MRP2 may play an important role in isoniazid-induced liver injury via the SIRT1/FXR pathway in rats and HepG2 cells[J].Biol Pharm Bull,2018,41(8):1211-1218.
[23] Weaver MJ,McHenry SA,Sayuk GS,et al.Bile acid diarrhea and NAFLD: shared pathways for distinct phenotypes[J].Hepatol Commun,2020,4(4):493-503.
[24] 黄倩,刘永刚,李京涛,等.消木丹颗粒对非酒精性脂肪肝大鼠FXR、ApoM表达的影响[J].南京中医药大学学报,2020,36(4):478-484.
[25] Schmitt J,Kong B,Stieger B,et al.Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal[J].Liver Int,2015,35(4):1133-1144.
[26] 邹逸凡,马明珠,赵钊,等.隔药饼灸对高脂血症合并动脉粥样硬化兔肝脏过氧化酶体增殖物激活型受体γ、B类Ⅰ型清道夫受体蛋白及基因表达的影响[J].针刺研究,2018,43(2):86-91.
[27] Shinohara S,Fujimori K.Promotion of lipogenesis by PPARγ-activated FXR expression in adipocytes[J].Biochem Biophys Res Commun,2020,527(1):49-55.
[28] 陈浩,李甲,胡蕾,等.基于Sirt1-FXR通路探究京尼平苷酸对胆汁淤积大鼠胆汁酸肝肠循环的影响[J].中国中药杂志,2019,44(4):787-795.
[29] Marra F,Svegliati-Baroni G.Lipotoxicity and the gut-liver axis in NASH pathogenesis[J].J Hepatol,2018,68(2):280-295.
[30] Devlin AS,Fischbach MA.A biosynthetic pathway for a prominent class of microbiota-derived bile acids[J].Nat Chem Biol,2015,11(9):685-690.
[31] Zheng X,Huang F,Zhao A,et al.Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice[J].BMC Biol,2017,15(1):120.
[32] Trabelsi MS,Lestavel S,Staels B,et al.Intestinal bile acid receptors are key regulators of glucose homeostasis[J].Proc Nutr Soc,2017,76(3):192-202.